Lamar SmithBuy
Inogen, Inc · Transaction Nov 20, 2018 · Filed Dec 13, 2018 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · INGN
+4.04% · +$0.2400 · Vol 243.9K
Market closed · last close 4:00 PM ET · price as of 16:26:49 ET
Inogen Inc
Health Care
$6.18
Follow $INGN
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $INGN by emailVeridion Score
BETAMEDIUM CONF · 5 of 6 factors measuredFri Oct 9 · market closed · Markets closed · resumes Mon 9:30 ET · INGN
MethodologySentiment absence reason unknown
INGN
Inogen Inc
Fri Oct 9 · market closed · Markets closed · resumes Mon 9:30 ET
Upper range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
70/ 100
Veridion Score
Upper range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5 of 6 factors measured · Fri Oct 9 · market closed · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is INGN moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Inogen Inc
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIESListed since
2014
Employees
753
Country
US
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$5.93
Day high
$6.28
Day low
$5.93
Previous close
$5.94
52W high
$8.95
-30.95% from high
52W low
$5.09
28% of range
Market cap
$157.6M
EPS
$-0.9048
Beta
0.09
Shares out
26.5M
Volume
243.9K
0.67× rel vol
Avg volume
361.7K
VWAP
$6.18
Price history computed in-house
1W
+3.52%
1M
+19.31%
3M
-5.50%
1Y
-24.26%
YTD
-8.04%
SMA 50 $5.63 · above
SMA 200 $6.22 · below
52W position 28%
INGN overview
Related filings and maps
Public disclosures
Congress activity in INGN
1 filers · 1 buys · 0 sells (0 labeled S (partial)) · Nov 20, 2018 to Nov 20, 2018 · House 1 / Senate 0
All available history · Latest 1 of 1 lines · Read 2026-10-10T03:48:46.303Z
Official filing ↗
Federal contracts
INGN contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for INGN in this window.
Lobbying spend
INGN lobbying filings, year to date.
Registered lobbying filings matched to Inogen Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for INGN in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for INGN.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.